Pfizer, we have started opening an investment center in it. It represents 4% of the portfolio, and I believe there is security in its traditional business, in the core links , the banks, everything, and the scale of the business there that should generate value over time.
There is always the possibility of a reversal of the profits that led to the stock's collapse, bringing it down to a value level and single-digit price-to-earnings ratios . Over time, it is expected to perform well.
They have returned to buyback operations , and recent earnings have been good. And if they manage to achieve their goal, or even half of it, let's say they reach $10 earnings per share in 2028 multiplied by 12, that's a really good return.
You're buying actual earnings , not past expectations that caused the stock to crash, but actual earnings.